Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma
Reed Friend, Manisha Bhutani, Peter M Voorhees, Saad Z Usmani Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, UNC School of Medicine, Charlotte, NC, USA Abstract: Elotuzumab is one of the first monoclonal antibodies to be approved for...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017-03-01
|
| coleção: | Drug Design, Development and Therapy |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/clinical-potential-of-slamf7-antibodies-ndash-focus-on-elotuzumab-in-m-peer-reviewed-article-DDDT |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|